MedPath

Ultra-Violet Fluorescence Bronchial Cancer Location

Not Applicable
Completed
Conditions
Lung Cancer
Interventions
Procedure: Rigid bronchoscopy with ultraviolet transmission
Other: Biopsy
Registration Number
NCT02533518
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

Diagnose lung cancer at an early stage is crucial for effective treatment. At these early stages, cancer is usually invisible in ambient white light when the endoscopic analysis of the bronchial mucosa. This lining is self-fluorescent at its illumination by blue light. These widely distributed autofluorescence methods detect early mucosal abnormalities. They are very sensitive but not specific to recognize the lung cancer. Thanks to European funding (EURIMUS), a new tool with fluorescent UV light has been developed.

The purpose of this preliminary study is to verify the suitability for specific detection of cancerous tissue in Pneumology of this fluorescence method versus histological analysis of the tissue.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patient affiliated or entitled to a social security scheme
  • Major Patient
  • Patient who signed the informed consent document
  • Patient with a known primary cancer in bronchial level
Exclusion Criteria
  • Pregnant woman
  • Patient with a benign tumor histology
  • Patient with an unknown tumor histology.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
patients with lung cancerBiopsy-
patients with lung cancerRigid bronchoscopy with ultraviolet transmission-
Primary Outcome Measures
NameTimeMethod
Histology of tissueDay 0

The histology give the final diagnosis

ultraviolet fluorescence ratio Iodine360 / Iodine450Day 0

Detection of cancerous tissues and healthy or inflammatory tissues is used to calculate the sensitivity and specificity of the rigid bronchoscopy with UV transmission compared to biopsy (gold standard).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pneumology departement CHU Saint-Etienne

🇫🇷

Saint-etienne, France

© Copyright 2025. All Rights Reserved by MedPath